高劑量普利多匹定用於治療亨廷頓舞蹈症的用途

• 收藏
• 分享

专利权人:

Teva Pharmaceuticals International GmbH

发明人:

Merav BASSAN,Eli EYAL,Esther, Lukasiewicz HAGAI,Anna, Kristina SVEINSDOTTER TEIGE WICKENBERG

申请号：

HK16109788.9

公开号：

HK1221646A

申请日:

2016.08.16

申请国别(地区):

HK

年份:

2017

代理人:

摘要：

A method of treating a human patient afflicted with Huntington's disease, comprising periodically orally administering to the patient a pharmaceutical composition comprising pridopidine or a pharmaceutically acceptable salt thereof such that greater than 90 mg of pridopidine is administered to the patient per day.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/